rs150103661
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_001242896.3(DEPDC5):c.1218-13_1218-10delGTTT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00117 in 1,602,800 control chromosomes in the GnomAD database, including 17 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0060 ( 7 hom., cov: 32)
Exomes 𝑓: 0.00067 ( 10 hom. )
Consequence
DEPDC5
NM_001242896.3 intron
NM_001242896.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.59
Genes affected
DEPDC5 (HGNC:18423): (DEP domain containing 5, GATOR1 subcomplex subunit) This gene encodes a member of the IML1 family of proteins involved in G-protein signaling pathways. The mechanistic target of rapamycin complex 1 (mTORC1) pathway regulates cell growth by sensing the availability of nutrients. The protein encoded by this gene is a component of the GATOR1 (GAP activity toward Rags) complex which inhibits the amino acid-sensing branch of the mTORC1 pathway. Mutations in this gene are associated with autosomal dominant familial focal epilepsy with variable foci. A single nucleotide polymorphism in an intron of this gene has been associated with an increased risk of hepatocellular carcinoma in individuals with chronic hepatitis C virus infection. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 22-31806103-CTGTT-C is Benign according to our data. Variant chr22-31806103-CTGTT-C is described in ClinVar as [Benign]. Clinvar id is 264754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31806103-CTGTT-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00598 (910/152294) while in subpopulation AFR AF= 0.02 (830/41566). AF 95% confidence interval is 0.0188. There are 7 homozygotes in gnomad4. There are 413 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 7 AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DEPDC5 | ENST00000651528.2 | c.1218-18_1218-15delTGTT | intron_variant | Intron 17 of 42 | NM_001242896.3 | ENSP00000498382.1 | ||||
ENSG00000285404 | ENST00000646701.1 | c.1134-18_1134-15delTGTT | intron_variant | Intron 15 of 20 | ENSP00000496158.1 |
Frequencies
GnomAD3 genomes AF: 0.00591 AC: 900AN: 152176Hom.: 6 Cov.: 32
GnomAD3 genomes
AF:
AC:
900
AN:
152176
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00163 AC: 402AN: 246514Hom.: 2 AF XY: 0.00129 AC XY: 173AN XY: 133970
GnomAD3 exomes
AF:
AC:
402
AN:
246514
Hom.:
AF XY:
AC XY:
173
AN XY:
133970
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000670 AC: 972AN: 1450506Hom.: 10 AF XY: 0.000598 AC XY: 432AN XY: 722422
GnomAD4 exome
AF:
AC:
972
AN:
1450506
Hom.:
AF XY:
AC XY:
432
AN XY:
722422
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00598 AC: 910AN: 152294Hom.: 7 Cov.: 32 AF XY: 0.00555 AC XY: 413AN XY: 74450
GnomAD4 genome
AF:
AC:
910
AN:
152294
Hom.:
Cov.:
32
AF XY:
AC XY:
413
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Aug 08, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
This variant is associated with the following publications: (PMID: 30093711) -
Oct 23, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Familial focal epilepsy with variable foci Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Epilepsy, familial focal, with variable foci 1 Other:1
-
GeneReviews
Significance: not provided
Review Status: no classification provided
Collection Method: literature only
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at